ARCHIVES

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

This article is from The Cancer Letter archive.

Vol. 32 No. 14 | April 14, 2006

Download PDF Visit The Full Archive

Related Articles

DCPC BSC Committee Endorses Three Research Concepts

April 17, 1987

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

March 3, 2000

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

Edelson to Direct Yale Cancer Center (12-page issue).

May 30, 2003

Scientists Brief Writers On Progress In Cancer Research

April 11, 1975